Browse Topic
Research
-
November 30, 2023Scientists find gene therapy reduces liver cancer in animal model
Researchers at the UC Davis Comprehensive Cancer Center have discovered that using gene therapy to inhibit a specific protein, galectin 1, can shrink liver cancer tumors in an animal model.
Read More -
November 29, 2023State stem cell agency, Shriners Children’s award $15 million to UC Davis CuRe trial
Fetal surgeon Diana Farmer and bioengineer Aijun Wang have been awarded $15 million by the state’s stem cell agency and Shriners Children’s to test their stem cell treatment for spina bifida.
Read More -
November 22, 2023Cancer blood tests jumpstart diagnoses and targeted therapy
DNA fragments circulating in patients’ blood can reveal the presence of tumors long before CT scans and lead to more agile use of cancer drugs.
Read More -
November 16, 2023Exploring the relationship between pediatric neuromuscular conditions and sleep-disordered breathing
In a review published in the journal Children, UC Davis pulmonologists explored the current diagnostic tools and treatments for pediatric patients with neuromuscular diseases and sleep-disordered breathing.
Read More -
November 02, 2023UC Davis bioengineer and neuroscientist receives NIH Director’s New Innovator Award
Christina Kim received the 2023 Director’s New Innovator Award from the NIH, providing her with $2.3 million in research funding.
Read More
-
October 31, 2023New report: Higher rates of lung, liver and other cancers among Californians living in poverty
A recent report illuminates disparities between cancer patients in persistent poverty and non-persistent poverty areas of California.
Read More -
October 26, 2023Viral reprogramming of cells increases risk of cancers in HIV patients
Cancer center scientists have identified a combination of biological effects that likely make some people with HIV vulnerable to cancer.
Read More -
October 25, 2023The missed cancer diagnoses: Impacts from COVID-19
Research shows that many cancers have likely gone undiagnosed during the pandemic, especially for California’s most vulnerable residents.
Read More -
October 25, 2023Meet the UC Davis Good Manufacturing Practice Facility’s new homegrown leader
A Q&A with the new director of UC Davis Good Manufacturing Practice (GMP) facility Brian Fury to learn about the GMP’s plans and recent California Institute for Regenerative Medicine (CIRM) $1.7 million award.
Read More -
October 23, 2023Researchers identify ‘switch’ to activate cancer cell death
UC Davis researchers identified a crucial mechanism that can cause cells to self-destruct. This new ability to trigger cell death could open the door for improved cancer treatments.
Read More -
October 20, 2023Researchers hope to study protein as an intervention for stroke patients
UC Davis Health researchers are part of a global study to determine whether giving stroke patients a high dose of a natural protein can improve stroke recovery.
Read More -
October 19, 2023Novel dynamic imaging technology captures the body’s immune response to COVID-19 infection
A UC Davis study shows the first-in-human imaging of the body’s CD8 T cell immune response to COVID-19 infection in recovering patients.
Read More -
October 13, 2023UC Davis neurology chair receives international honor for research
UC Davis Health Department of Neurology Chair Amy Brooks-Kayal is the 2023 recipient of the prestigious Child Neurology Society Bernard Sachs Award.
Read More -
October 12, 2023Study explores how changing autism traits are linked to mental health conditions
A study of autistic children ages 6-11 finds a relationship between changes in the intensity of autism traits and increases in mental health challenges.
Read More -
October 10, 2023Prescription drug monitoring: Updating California’s patient safety alerts
The UC Davis Center for Healthcare Policy and Research was awarded the 2023 Harold Rogers Prescription Drug Monitoring Program grant to develop updated patient safety alerts.
Read More -
October 09, 2023Research symposium unites scientists passionate about fighting cancer
UC Davis Comprehensive Cancer Center’s 29th Annual Cancer Research Symposium reports out on latest progress in cancer fight.
Read More -
October 05, 2023New study looks at attitudes towards political violence
A new UC Davis study reveals a complex mix of attitudes, concerns and beliefs about the state of democracy and the potential for violence in the U.S.
Read More
-
September 27, 2023New California Tobacco Cessation Policy Research Center to be housed at cancer center
California’s new Tobacco Cessation Policy Research Center will be located at UC Davis Comprehensive Cancer Center and funded with a $3.7 million state grant.
Read More -
September 25, 2023UC Davis developing models to predict the excitability of brain neuronal circuits
Researcher Roy Ben-Shalom is developing a model that simulates changes in neuronal activity caused by ion channel mutations to select the most effective therapy for many neurodevelopmental conditions.
Read More -
September 20, 2023First Wilson Disease patient receives gene therapy at UC Davis Health
Researchers have infused their first Wilson Disease patient with a gene therapy which has the potential to treat the underlying cause of the disease.
Read More